The homogeneous mutation status of a 22 gene panel justifies the use of serial sections of colorectal cancer tissue for external quality assessment

Testing for treatment related biomarkers in clinical care, like Ras mutation status in colorectal cancer (CRC), has increased drastically over recent years. Reliable testing of these markers is pivotal for optimal treatment of patients. Participation in external quality assessment (EQA) programs is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Virchows Archiv : an international journal of pathology 2015-09, Vol.467 (3), p.273-278
Hauptverfasser:	Dijkstra, Jeroen R., Tops, Bastiaan B. J., Nagtegaal, Iris D., van Krieken, J. Han J. M., Ligtenberg, Marjolijn J. L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers, Tumor - analysis Biomarkers, Tumor - genetics Colorectal carcinoma Colorectal Neoplasms - genetics DNA Mutational Analysis - methods Formaldehyde Genotype Heterogeneity High-Throughput Nucleotide Sequencing Humans Medicine Medicine & Public Health Mutation Original Original Article Paraffin Embedding Pathology Quality Assurance, Health Care - methods Tissue Fixation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!